Clinical Trials for Eyelid Disorders

Currently registered clinical trials for Eyelid Disorders from ClinicalTrials.gov. 17 recruiting, 50 total studies.

This content is for informational purposes only. Always consult a healthcare professional.

Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).

This page lists clinical trials related to Eyelid Disorders from the ClinicalTrials.gov database.

Trial Summary

  • Total studies: 50
  • Recruiting: 17
  • Active, not recruiting: 2
  • Completed: 16
  • Other: 15

Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.

Recruiting Trials

NCT03767530 — Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction

StatusRecruiting
PhaseN/A
SponsorUniversidad Autonoma de Nuevo Leon
Enrollment42
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction
Interventions;

Dry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfunction. Meibomian glands are very small glands located at the rim of the eyelids that produce an oily substance that prevents the evaporation of tears. When these glands are compromised, the tear film evaporates quickly and the eyes dry u…

NCT04140734 — Spacer Graft Study

StatusRecruiting
PhaseN/A
SponsorMontefiore Medical Center
Enrollment100
Study TypeINTERVENTIONAL
ConditionsEyelid Diseases; Eyelid Droop
Interventions

To determine which of three types of spacer grafts (hard palate vs autologous ear cartilage vs Enduragen) are the most effective in lower eyelid retraction repair outcomes as measured by MRD2 (margin to reflex distance 2)

NCT04068155 — Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

StatusRecruiting
PhaseN/A
SponsorAlpha Tau Medical LTD.
Enrollment80
Study TypeINTERVENTIONAL
ConditionsSkin Cancer; Cutaneous Tumor; Cutaneous Metastasis
Interventions

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

NCT07634913 — Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye

StatusRecruiting
PhaseN/A
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment3000
Study TypeOBSERVATIONAL
ConditionsArtifical Intelligence; Cataract; Pterygium; Keratopathy; Subconjunctival Hemorrhage
Interventions

This is a multi-center, cross-sectional study evaluating a smartphone-based artificial intelligence (AI) system for anterior segment eye disease screening. The system is designed to identify 16 clinically important anterior segment conditions from images captured using a standard Android smartphone. A core design feature of the system is that all image analysis is performed entirely on the smar…

NCT06291818 — Self-Adhering Magnetic Device to Treat Corneal Exposure

StatusRecruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Enrollment25
Study TypeINTERVENTIONAL
ConditionsParalytic Lagophthalmos; Corneal Exposure
Interventions

Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. W…

NCT06371300 — Photobiomodulation With REd vs BluE Light (REBEL)

StatusRecruiting
PhaseN/A
SponsorAston University
Enrollment36
Study TypeINTERVENTIONAL
ConditionsDry Eye Syndromes; Meibomian Gland Dysfunction; Blepharitis
Interventions; ;

The use of photobiomodulation or low-level light therapy (LLLT) in the ophthalmic field stemmed from dermatology which has shown impact on skin blood flow and regeneration. There has been a rise in clinical interest with emerging evidence in the benefits of photobiomodulation in managing chronic inflammatory conditions such as dry eye disease including improvements in ocular discomfort symptoms…

NCT06683651 — A Study in Chinese Patients With Acquired Blepharoptosis

StatusRecruiting
PhasePhase 3
SponsorSanten Pharmaceutical Co., Ltd.
Enrollment180
Study TypeINTERVENTIONAL
ConditionsBlepharoptosis
Interventions;

This is a Phase III Study to evaluate the efficacy and safety of STN1013800 Ophthalmic Solution in Chinese Patients with Acquired Blepharoptosis.

At present, there are no medicines for the treatment of acquired blepharoptosis in China.

Therefore, to evaluate the efficacy and safety of 0.1% STN1013800 ophthalmic solution, Vehicle (Placebo) are designed.

For the screening period, 3-7 days were…

NCT06220474 — Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

StatusRecruiting
PhaseN/A
SponsorThe University of Hong Kong
Enrollment112
Study TypeINTERVENTIONAL
ConditionsDry Eye Syndromes; Meibomian Gland Dysfunction
Interventions;

The goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX alone in patients with meibomian gland dysfunction-related dry eye disease. The main question it aims to answer is whether radiofrequency treatment and meibomian gland expression is more effective in improving tear breakup time, as meas…

NCT07450495 — Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery

StatusRecruiting
PhaseN/A
SponsorJoint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong
Enrollment80
Study TypeINTERVENTIONAL
ConditionsChalazion
Interventions

This randomized controlled trial aims to compare the effectiveness and safety of 6% versus 8% sevoflurane inhalation induction in pediatric patients undergoing minor ophthalmic surgery. The primary outcome is emergence agitation assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale. Secondary outcomes include hemodynamic parameters, induction time, recovery time, and adverse e…

NCT06743490 — Capturing Key MG-symptoms Using Smartphone Recordings.

StatusRecruiting
PhaseN/A
SponsorLeiden University Medical Center
Enrollment225
Study TypeOBSERVATIONAL
ConditionsMyasthenia Gravis; Fatigue

This study will make use of a cross-sectional design of MG patients and non-MG participants to quantitatively assess key MG symptoms, and to explore the applicability of machine learning algorithms to their measurement.

NCT06895902 — Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy

StatusRecruiting
PhaseEarly Phase 1
SponsorUniversity of Alberta
Enrollment10
Study TypeINTERVENTIONAL
ConditionsFacial Nerve Palsy; Corneal Exposure; Paralytic Lagophthalmos
Interventions

The eyelids protect the cornea and eyelid closure is essential to ocular health and clear vision.

Patients with permanent Bells palsy or facial nerve palsy from other reasons such as tumours or trauma may be unable to blink and protect their cornea.

Irreversible visual loss can occur if the cornea is not kept lubricated.

Current treatment options for patients whose eyelid blink does not reco…

NCT07534436 — A Prospective Cohort Study on Visual Function and Psychological Conditions Before and After Surgery for Congenital Ptosis

StatusRecruiting
PhaseN/A
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment73
Study TypeOBSERVATIONAL
ConditionsPtosis

The goal of this observational study is to learn about the 6-month effects of Levator Resection combined with Fascial Sheath Suspension surgery in patients who undergo this procedure to treat congenital ptosis. The main questions it aims to answer are:

Does this combined surgery improve best-corrected visual acuity, stereopsis, and other visual function indicators in patients with congenital p…

NCT07431385 — Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

StatusRecruiting
PhaseN/A
SponsorFidia Farmaceutici s.p.a.
Enrollment80
Study TypeINTERVENTIONAL
ConditionsBlepharitis; Blepharoconjunctivitis
Interventions

The study will evaluate the clinical improvement in ocular symptoms using IRIDIUM GARZE as adjuvant treatment in patients suffering of blepharitis or blepharoconjunctivitis as primary objective. The Change from baseline (T0) to Day 28 (T2) in overall ocular discomfort (Global Discomfort Score - GDS) using a 0-10 numeric rating scale (NRS) in the target eye. Subjects with a change from baseline …

NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy

StatusRecruiting
PhaseN/A
SponsorSingapore National Eye Centre
Enrollment30
Study TypeOBSERVATIONAL
ConditionsDry Eye; Meibomian Gland Dysfunction (Disorder)

The purpose of this research study is to understand the mechanism of action of low level light therapy and also potentially yield markers associated with good treatment response. Low-level light therapy is light-based treatment delivered through advance eye-light device. This therapy uses light energy to provide energy to the meibomian gland cells to slow down age-ing, improve tear stability an…

NCT07322302 — RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

StatusRecruiting
PhaseN/A
SponsorUniversity of North Carolina, Chapel Hill
Enrollment1000
Study TypeINTERVENTIONAL
ConditionsTrachoma; Eye Diseases; Trichiasis
Interventions;

The primary objective of this randomized clinical trial is to determine whether repeat trichiasis surgery performed with Bevel-Rotate Advancement Procedure (B-RAP) improves surgical success compared to Bilamellar Tarsal Rotation (BLTR) among a group of 8-10 TT surgeons in Tanzania. The study aims to enroll 1,000 individuals with PTT. The primary outcome is repeat PTT within one year after surge…

NCT07606625 — Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

StatusRecruiting
PhasePhase 4
SponsorUniversity of California, Berkeley
Enrollment65
Study TypeINTERVENTIONAL
ConditionsDry Eye; Meibomian Gland Dysfunction
Interventions

The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).

NCT07224529 — Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

StatusRecruiting
PhasePhase 4
SponsorUniversity of Alabama at Birmingham
Enrollment48
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction (MGD)
Interventions

This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye condition that can cause dry, irritated, or burning eyes.

If you join the study, after a short “run-in” period using artificial tears, you will receive Vevye twice a day for about 24 weeks (approximately six months). During that time you wi…

Active, Not Recruiting

NCT06511453 — Acupressure in Patients With Sickle Cell Disease

StatusActive, not recruiting
PhaseN/A
SponsorIndiana University
Enrollment300
Study TypeINTERVENTIONAL
ConditionsSickle Cell Disease
Interventions;

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

NCT06720896 — A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.

StatusActive, not recruiting
PhasePhase 2
SponsorAperta Biosciences, LLC
Enrollment100
Study TypeINTERVENTIONAL
ConditionsBlepharitis
Interventions;

The purpose of this study is to establish the clinical efficacy of APT-001 topical therapy 1.8% in patients with blepharitis as compared to its vehicle control, and to establish that the therapeutic is safe and generally well tolerated by patients.

Not Yet Recruiting

NCT07405138 — Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

StatusNot yet recruiting
PhaseN/A
SponsorLumenis Be Ltd.
Enrollment40
Study TypeINTERVENTIONAL
ConditionsChalazion
Interventions;

To study the effectiveness and safety of IPL treatment for Chalazion

StatusNot yet recruiting
PhaseN/A
SponsorAsociación para Evitar la Ceguera en México
Enrollment28
Study TypeINTERVENTIONAL
ConditionsDry Eye Syndromes; Meibomian Gland Dysfunction (Disorder)
Interventions;

This randomized clinical trial aims to evaluate if a blink reminder program (‘BlinkEasy’) reduces the progression of Meibomian gland loss in intensive digital screen users over three months , using infrared meibography as the primary structural measure. Additionally, the study will analyze changes in dry eye symptoms using the 12-item Ocular Surface Disease Index (OSDI) questionnaire and non-in…

NCT07418333 — Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.

StatusNot yet recruiting
PhaseN/A
SponsorVISUfarma SpA
Enrollment100
Study TypeINTERVENTIONAL
ConditionsCataract Surgery; Ocular Infections
Interventions

This is an interventional, open-label, two-arms clinical trial, randomized 1:1 (EPD treatment or no eyelid hygiene treatment) in patients scheduled for eye surgery (cataract surgery). The purpose of the study is to evaluate the importance of the cleansing action of EPD-09-25 before and after eye surgery.

NCT07561450 — Demodex Blepharitis in Scleral Lens Wearers

StatusNot yet recruiting
PhasePhase 4
SponsorBoston Sight
Enrollment5
Study TypeINTERVENTIONAL
ConditionsDemodex Blepharitis
Interventions

The purpose of this study will be to see if Xdemvy (lotilaner ophthalmic solution) 0.25% has a positive impact on ocular surface symptoms and PROSE device functionality and performance.

The investigators hypothesize the use of Xdemvy in subjects utilizing PROSE treatment will be well tolerated and that the reduction in Demodex mite load on the eyelid margin will result in reduced ocular surfac…

NCT07481500 — Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: A Randomized Trial of Pain, Procedure Time, Patient Satisfaction, and Safety

StatusNot yet recruiting
PhaseN/A
SponsorJakkrit Juhong
Enrollment120
Study TypeINTERVENTIONAL
ConditionsNeovascular Age-Related Macular Degeneration (nAMD); Diabetic Macular Edema; Retinal Vein Occlusion; Intravitreal Injections
Interventions;

This randomized controlled trial compares two techniques for eyelid retraction during intravitreal injection (IVI) of anti-VEGF agents: the standard wire eyelid speculum (Group A) versus cotton-tipped applicator retraction (Group B) in patients with neovascular AMD, diabetic macular edema, or retinal vein occlusion.

The study evaluates four outcomes: (1) patient pain perception measured by a 1…

NCT07562594 — Eyelid Taping Alone Versus Taping With Lubricant Eye Drops for Perioperative Corneal Protection

StatusNot yet recruiting
PhaseN/A
SponsorFatih Sultan Mehmet Training and Research Hospital
Enrollment200
Study TypeINTERVENTIONAL
ConditionsCorneal Injury; Exposure Keratopathy; Perioperative Complications
Interventions;

During general anesthesia, the eye’s natural protective reflexes are suppressed, which can lead to corneal drying and injury. To prevent this, anesthesiologists routinely tape the eyelids closed. In many centers, lubricant eye drops are also applied in addition to taping, but whether this adds meaningful protection is unclear.This study will compare two approaches to eye protection during gener…

NCT07496515 — Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia

StatusNot yet recruiting
PhasePhase 2
SponsorJaeb Center for Health Research
Enrollment168
Study TypeINTERVENTIONAL
ConditionsPediatric Chalazia
Interventions; ;

Participants enrolled into the study will be prescribed twice daily warm compresses for 8 weeks and randomly allocated (1:1:1) to receive either 1) Oral omega-3 supplementation and standard eyelid cleanser, 2) Anti-Demodex eyelid cleanser, or 3) Standard eyelid cleanser as treatment for chalazia.

Participants will return for a visit after 8 weeks for a masked clinical exam to determine whether…

NCT07633938 — The Effect of Eyelid Support Plate Assisted Eyelid Massage on Meibomian Gland Dysfunction: a Randomized Controlled Trial

StatusNot yet recruiting
PhaseN/A
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment142
Study TypeINTERVENTIONAL
ConditionsDry Eye Disease (DED); MGD-Meibomian Gland Dysfunction
Interventions;

This study aims to conduct a randomized controlled clinical trial to compare the efficacy of a new type of massage device - eyelid support plate and glass rod assisted eyelid massage in improving MGD related dry eye symptoms, and evaluate the comfort and efficiency of both treatments, providing evidence-based support for clinical work

NCT07489430 — DaxibotulinumtoxinA for Blepharospasm

StatusNot yet recruiting
PhasePhase 2
SponsorUniversity of Pennsylvania
Enrollment20
Study TypeINTERVENTIONAL
ConditionsBlepharospasm of Both Eyelids; Blepharospasm of Left Eyelid; Blepharospasm of Right Eyelid; Blepharospasm, Benign Essential; Blepharospasm
Interventions

This study aims to provide real-world information about the duration, safety, and overall benefit of DaxibotulinumtoxinA (also called DAXI) treatment for adults living with blepharospasm (BSP), a condition that causes uncontrolled blinking or muscle spasms around the eyes, which can interfere with vision and daily activities. Specifically, it is being done to learn more about how well and how l…

NCT07662785 — Topical 2% Simvastatin for Xanthelasma Palpebrarum

StatusNot yet recruiting
PhasePhase 2
SponsorKlira Skin
Enrollment30
Study TypeINTERVENTIONAL
ConditionsXanthelasma Palpebrarum
Interventions;

This study is evaluating whether a topical cream containing 2% simvastatin can improve xanthelasma palpebrarum, a common condition that causes yellow cholesterol deposits on the eyelids. Current treatments such as surgery, laser therapy, and chemical treatments can be effective but may cause scarring, pigment changes, or recurrence.

In this randomized, double-blind, vehicle-controlled trial, 3…

NCT07579156 — TearCare in Young Adults

StatusNot yet recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Enrollment45
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction (Disorder)
Interventions

This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs at Day 28.

NCT07390578 — Upneeq vs. Lumify Ptosis

StatusNot yet recruiting
PhasePhase 4
SponsorDuke University
Enrollment50
Study TypeINTERVENTIONAL
ConditionsAcquired Ptosis
Interventions;

This study aims to compare the short-term effect of oxymetazoline 0.1% (Upneeq) versus brimonidine 0.025% (Lumify) on upper-eyelid position in adults with acquired ptosis. Participants will undergo standardized eyelid photography, receive a single dose of either Upneeq or Lumify in randomized order, and have repeat photographs approximately 60 minutes later. They will return for a second visit …

Enrolling by Invitation

NCT07453212 — Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction

StatusEnrolling by invitation
PhaseN/A
SponsorVarol TUNALI
Enrollment130
Study TypeINTERVENTIONAL
ConditionsDry Eye; Evaporative Dry Eye Disease; Meibomian Gland Dysfunction (Disorder)
Interventions;

Dry eye disease (DED) is a common chronic condition characterized by ocular surface discomfort and tear film instability. Evaporative DED associated with meibomian gland dysfunction (MGD) is a frequent phenotype and is often driven by inflammatory mechanisms. This randomized, double-blind, placebo-controlled trial evaluates whether an oral microbiome-focused food supplement improves dry eye sym…

Completed Trials

NCT01432821 — Blinking and Yawning in Epilepsy: The Role of Dopamine

StatusCompleted
PhaseN/A
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Enrollment31
Study TypeINTERVENTIONAL
ConditionsIdiopathic Generalized Epilepsy
Interventions

The objective of the present study is to assess dopaminergic reactivity with behavioural markers (i.e. yawning and blinking) in patients with idiopathic generalized epilepsy compared to matched healthy controls, after injection of either low dose of apomorphine or placebo.

Other parameters will be recorded: biochemical (prolactin, GH) and neurophysiological (Spike-Waves Discharge: SWD rating)….

NCT04149210 — FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

StatusCompleted
PhasePhase 3
SponsorMassachusetts Eye and Ear Infirmary
Enrollment2410
Study TypeINTERVENTIONAL
ConditionsTrachomatous Trichiasis (TT); Eye Diseases; Eyelid Diseases; Trachomatous; Trichiasis
Interventions;

This study aims :

  • To assess the efficacy of fluorometholone 0.1% one drop twice daily for four weeks in reducing the incidence of post-operative trachomatous trichiasis (TT) when given as adjunctive therapy with TT surgery in the programmatic setting
  • To assess whether such treatment is sufficiently safe for wide-scale implementation in TT programs.
  • To estimate the costs of adding fluorom…

NCT05577910 — Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD

StatusCompleted
PhaseN/A
SponsorChinese University of Hong Kong
Enrollment374
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction
Interventions; ;

Meibomian gland dysfunction (MGD), closely associated with Dry Eye Disease (DED), is a chronic condition where terminal ducts are obstructed and/or glandular secretion changes. The efficacy of traditional treatment options, e.g. eyelid warm compress therapy (EW) is limited with low compliance. This study aims to (1)compare the efficacy and safety of two emerging alternatives- vectored thermal p…

NCT07621952 — Meibomian Gland Changes in Ocular Prosthesis Users

StatusCompleted
PhaseN/A
SponsorInstituto de Oftalmología Fundación Conde de Valenciana
Enrollment20
Study TypeOBSERVATIONAL
ConditionsDry Eye; Meibomian Gland Dysfunction (Disorder); Anophthalmic Socket Syndrome; Ocular Prostheses
Interventions

This observational cross-sectional study aims to evaluate meibomian gland loss and dry eye symptoms in patients using unilateral ocular prostheses. The study compares the prosthetic eye with the contralateral healthy eye using the DEQ-5 questionnaire and meibography obtained with the Oculus Keratograph 5M. Additional ocular surface parameters, including conjunctival hyperemia and tear meniscus …

NCT06004895 — Mechanisms of Light-based Therapies for Dry Eye Disease

StatusCompleted
PhaseN/A
SponsorAston University
Enrollment26
Study TypeINTERVENTIONAL
ConditionsDry Eye Syndromes; Meibomian Gland Dysfunction
Interventions; ;

Dry eye disease is a common condition affecting millions worldwide and costing millions in healthcare due to reduced work productivity and quality of life. The disruption of oil glands in our eyelids known as Meibomian glands, which produce the oily layer of our tears to protect it from evaporating, is one of the most common contributors of dry eye disease. Much effort has been put into develop…

NCT05945615 — Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

StatusCompleted
PhasePhase 3
SponsorMilton S. Hershey Medical Center
Enrollment36
Study TypeINTERVENTIONAL
ConditionsBlepharoptosis; Synkinesis; Hyperkinesis; Facial Paralysis
Interventions;

After an episode of facial paralysis, as nerves recover, they aberrantly regenerate and send additional branches to the incorrect muscles in addition to the intended muscle. This leads to what is known as Aberrant Regeneration Syndrome, Post-paralysis Synkinesis, or Nonflaccid Facial Paralysis. It is characterized by poor facial symmetry and function, hypertonic facial muscles at rest, and abno…

NCT06279143 — The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

StatusCompleted
PhaseN/A
SponsorVejle Hospital
Enrollment210
Study TypeOBSERVATIONAL
ConditionsBCC - Basal Cell Carcinoma; BCC; Skin Diseases; Eyelid Tumor; Eyelid Diseases

The purpose is to investigate the diagnostic value (sensitivity and specificity) of dermal-Optical Coherence Tomography (D-OCT, VivoSight Dx), in patients with clinically suspected BCC lesions inside the periocular region and compare these results to previous reports using D-OCT in diagnosing lesions outside the periocular area.

The Hypotheses:

  • The sensitivity and specificity of D-OCT in di…

NCT06483750 — Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

StatusCompleted
PhaseN/A
SponsorGeorge Washington University
Enrollment30
Study TypeINTERVENTIONAL
ConditionsDry Eye Disease; Meibomian Gland Dysfunction; Cataract Senile; Dry Eye Syndromes
Interventions

This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

NCT07471997 — Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

StatusCompleted
PhaseN/A
SponsorInstituto de Oftalmología Fundación Conde de Valenciana
Enrollment15
Study TypeINTERVENTIONAL
ConditionsThyroid Eye Disease, TED
Interventions

Thyroid eye disease frequently causes upper eyelid retraction, which can lead to ocular surface complications and cosmetic concerns. Several medical and surgical treatments have been proposed; however, minimally invasive therapies remain of interest.

This study evaluates the efficacy of local triamcinolone acetonide injection administered through transconjunctival and transseptal routes for th…

NCT06400459 — IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease

StatusCompleted
PhasePhase 1 / Phase 2
SponsorIVIEW Therapeutics Inc.
Enrollment150
Study TypeINTERVENTIONAL
ConditionsDry Eye Disease
Interventions; ;

Double-masked, dose-response, trial of IVW-1001 in subjects with dry eye disease.

NCT07451678 — Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine

StatusCompleted
PhasePhase 4
SponsorInstituto de Oftalmología Fundación Conde de Valenciana
Enrollment39
Study TypeINTERVENTIONAL
ConditionsBlepharitis
Interventions

This study employed an experimental, prospective, longitudinal, before-and-after design to evaluate the efficacy of topical chlorhexidine wipes in treating blepharitis.

The investigation focused on assessing signs and symptoms associated with Demodex Folliculorum blepharitis, including telangiectasia, ocular irritation, collarettes, foreign body sensation, tearing, eyelid erythema, and dry eye…

NCT07618169 — Comparative Effects of USB-Powered Warm Compress and Self-Heating Eye Mask in the Management of Meibomian Gland Dysfunction

StatusCompleted
PhaseN/A
SponsorKing Saud University
Enrollment15
Study TypeINTERVENTIONAL
ConditionsDry Eye; MGD-Meibomian Gland Dysfunction
Interventions;

Why was this study done?

People with Meibomian Gland Dysfunction (MGD) often have dry, irritated eyes because the tiny oil glands in their eyelids do not work properly. Applying gentle heat to the eyelids is a common way to improve the flow of oil and relieve symptoms.

This study wanted to find out whether a USB-powered warm compress or a self-heating disposable eye mask works better and feel…

NCT07140380 — Phase 2b Controlled Study

StatusCompleted
PhasePhase 2
SponsorIVIEW Therapeutics Inc.
Enrollment30
Study TypeINTERVENTIONAL
ConditionsDry Eye Disease
Interventions

Double-masked two period controlled trial of three eyelid wipe dosing techniques

NCT07161011 — Phase 2b Controlled Study of Dosing Techniques - Part B

StatusCompleted
PhasePhase 2
SponsorIVIEW Therapeutics Inc.
Enrollment15
Study TypeINTERVENTIONAL
ConditionsDry Eye
Interventions;

Double-masked, dose-response of two concentrations of IVW-1001

NCT07148271 — Effect of a Dietary Supplement on Gut Microbiota and Ocular Surface Outcomes in Dry Eye Disease

StatusCompleted
PhaseN/A
SponsorVarol TUNALI
Enrollment20
Study TypeINTERVENTIONAL
ConditionsDry Eye; Meibomian Gland Dysfunction (Disorder); Dry Eye Disease (DED); Dry Eye Disease, Meibomian Gland Disease
Interventions

This prospective clinical study investigates whether a dietary supplement product can modulate the gut microbiota and improve ocular surface outcomes in patients with dry eye disease. Participants will be recruited from Istanbul Medipol University Hospital (Department of Ophthalmology) and Liv Hospitals (Vadi Istanbul and Ulus). Each participant will receive the dietary supplement product for 8…

NCT07365735 — TearCare MGX™ System With and Without Warming Hold

StatusCompleted
PhaseN/A
SponsorSight Sciences, Inc.
Enrollment21
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction (Disorder)
Interventions

TearCare is an office-based thermal therapeutic eyelid technology cleared by the US Food and Drug Administration for the treatment of evaporative dry eye disease due to meibomian gland dysfunction. In this randomized study, TearCare procedures using the TearCare MGX System (study device) with the extended Warming hold feature will be compared with TearCare procedures using the TearCare MGX Syst…

Other (Withdrawn)

NCT04920396 — Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction

StatusWithdrawn
PhaseN/A
SponsorAston University
EnrollmentN/A
Study TypeINTERVENTIONAL
ConditionsMeibomian Gland Dysfunction
Interventions;

This study is to evaluate the effectiveness of E>EYE intense regulated pulsed light (IRPL) treatment compared to the current standard of care using a daily warm compress

Other (Terminated)

NCT06400511 — A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

StatusTerminated
PhasePhase 3
SponsorFamy Life Sciences, a Viatris Company
Enrollment477
Study TypeINTERVENTIONAL
ConditionsBlepharitis
Interventions;

The objective of this study is to determine the efficacy and safety of Pimecrolimus 0.3% (MR-139) Ophthalmic Ointment.